Competitor Analysis: HIV Small Molecule Therapeutics

Date: December 1, 2011
Pages: 100
Price:
US$ 642.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C67B9044E7FEN
Leaflet:

Download PDF Leaflet

Competitor Analysis: HIV Small Molecule Therapeutics
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
Index
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
  • Nucleoside Reverse Transcriptase Inhibitor (NRTI)
  • Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
  • HIV Protease Inhibitors
  • HIV Integrase Inhibitors
  • HIV Fusion & Entry Inhibitors
  • HIV Maturation Inhibtors
  • Others
  • Dual Combination Drugs
  • Triple Combination Drugs
  • Quadruple Combination Drugs
  • About La Merie
About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
  • Nucleoside Reverse Transcriptase Inhibitor (NRTI)
  • Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
  • HIV Protease Inhibitors
  • HIV Integrase Inhibitors
  • HIV Fusion & Entry Inhibitors
  • HIV Maturation Inhibtors
  • Others
  • Dual Combination Drugs
  • Triple Combination Drugs
  • Quadruple Combination Drugs
  • About La Merie
Skip to top


Competitor Analysis: Anthrax Vaccines & Therapeutics US$ 257.00 Jun, 2013 · 32 pages
Competitor Analysis HIV Vaccines US$ 413.00 Oct, 2011 · 54 pages

Ask Your Question

Competitor Analysis: HIV Small Molecule Therapeutics
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: